Direkt zum Inhalt
Merck

Evaluation of tetrafunctional block copolymers as synthetic vectors for lung gene transfer.

Biomaterials (2015-02-11)
Peggy Richard-Fiardo, Catherine Hervouet, Robert Marsault, Philippe R Franken, Béatrice Cambien, Julien Guglielmi, Julie Warnez-Soulie, Jacques Darcourt, Thierry Pourcher, Thibault Colombani, Thomas Haudebourg, Pauline Peuziat, Bruno Pitard, Georges Vassaux
ZUSAMMENFASSUNG

In the present study, we evaluated, in mice, the efficacy of the tetrafunctional block copolymer 704 as a nonviral gene delivery vector to the lungs. SPECT/CT molecular imaging of gene expression, biochemical assays, and immunohistochemistry were used. Our dataset shows that the formulation 704 resulted in higher levels of reporter gene expression than the GL67A formulation currently being used in a clinical trial in cystic fibrosis patients. The inflammatory response associated with this gene transfer was lower than that induced by the GL67A formulation, and the 704 formulation was amenable to repeated administrations. The cell types transfected by the 704 formulation were type I and type II pneumocytes, and transgene expression could not be detected in macrophages. These results emphasize the relevance of the 704 formulation as a nonviral gene delivery vector for lung gene therapy. Further studies will be required to validate this vector in larger animals, in which the lungs are more similar to human lungs.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Hämatoxylin
Sigma-Aldrich
Kalium, chunks (in mineral oil), 98% trace metals basis
Sigma-Aldrich
Hämatoxylin, certified by the BSC
Sigma-Aldrich
Kaliumhydrid, 30 wt % dispersion in mineral oil
Sigma-Aldrich
Kaliumhydrid, in paraffin
Isofluran, European Pharmacopoeia (EP) Reference Standard